@Article{Bobrowska2022,
journal="Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej",
issn="1734-9338",
volume="18",
number="2",
year="2022",
title="Effectiveness and safety of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with familial hypercholesterolemia. Our experience in implementing the drug program of the Polish National Health Fund",
author="Bobrowska, Beata
and Krawczyk-Ożóg, Agata
and Bartuś, Stanisław
and Rajtar-Salwa, Renata",
pages="162--166",
doi="10.5114/aic.2022.118533",
url="http://dx.doi.org/10.5114/aic.2022.118533"
}